Annenberg CPB  Home  |  Channel  |  Video Catalog  |  About Us  |  Search  |  Contact Us  
Rediscovering Biology Logo
Home
Online TextbookCase StudiesExpertsArchiveGlossarySearch
Unit 5: Emerging Infectious Diseases
Back to Unit Page
Unit Content
Unit Textbook Chapter
Animations & Images
Expert Interview Transcripts
Unit Glossary
Related Resources
Unit Activities  
Capt. Daniel Carucci, M.D., PhD
Director, NMRC Malaria Program
Dr. Carucci is the Director of the Malaria Program at the Naval Medical Research Center where he oversees Navy research efforts on malaria, focusing on vaccine development and novel approaches to protecting individuals from the disease. He is also the Department of Defense coordinator for the Malaria Genome Project, where he oversees all DoD sponsored research in malaria genomics and proteomics.

Rita Colwell, PhD
Marine Microbiologist
Dr. Colwell is a Marine Microbiologist and serves at the President of the National Science Foundation. She is an advocate of an integrated approach to studying disease called biocomplexity, giving a holistic, system-wide view of the causation and effects of disease. She was pioneer in the research done on the Cholera epidemics in Bangladesh. She was able to help define causation and drastically reduce disease in the communities through public health education.

Stuart B. Levy, M.D.
Scientist, Environmental Defense
Dr. Levy is a professor of Molecular and Microbiology and a professor of Medicine at Tufts University in Boston, Massachusetts where he researches the Tetracycline Efflux Protein. He is also the President of the Alliance for the Prudent Use of Antibiotics, which is an organization that aims to promote responsible and appropriate use of antibiotics around the world.

Judith M. Martin, M.D.
Pediatric Infectious Disease


Lukas K. Tamm, PhD
Professor of Biophysics, University of Virginia
Tamm is a professor of Biophysics at the University of Virginia where he is studying the structures and interactions of viral fusion proteins in lipid bilayers, mainly using the influenza surface protein, hemagglutinin (HA). This research opens possibilities to develop new classes of viral entry inhibitors, which would serve to prevent influenza infection.


  Home  |  Catalog  |  About Us  |  Search  |  Contact Us

| Follow The Annenberg Learner on Facebook
 

  © Annenberg Foundation 2013. All rights reserved.
Privacy Policy